GENOME ANNOUNCEMENT
===================

*Staphylococcus aureus* is an important human pathogen equipped with an arsenal of virulence and antimicrobial resistance genes ([@B1]), thus making it one of the leading pathogens causing bloodstream infections in the hospital setting and within the community. Some *S. aureus* strains produce Panton-Valentine leukocidin (PVL), a bicomponent cytotoxin encoded in the PVL prophage that is made up of two protein components designated Luk-S-PV and Luk-F-PV, which function to destroy leukocytes by creating pores in the cell membranes ([@B2]). *S. aureus* strain KT/Y21 was isolated from a blood sample from a newborn patient with septicemia in the pediatric intensive care unit (PICU) of the main tertiary referral hospital in Kuala Terengganu, Malaysia. Phenotypic identification was confirmed by a MicroLog system (version 4.2) (Biolog, Inc., Hayward, CA), and antimicrobial susceptibility testing profiles indicated that strain KT/Y21 is multidrug resistant, with resistances toward cefoxitin, ciprofloxacin, fusidic acid, gentamicin, kanamycin, mupirocin, neomycin, oxacillin, penicillin, and tobramycin.

Genome sequencing of *S. aureus* KT/Y21 was performed using the Illumina Genome Analyzer IIx with 100-bp paired-end reads. The paired-end reads were trimmed and assembled *de novo* using CLC Genomics Workbench 5.1 (CLC bio, Denmark). The draft genome was annotated using Blast2GO 2.5.0 ([@B3]) and subsequently validated using Rapid Annotation Subsystems Technology (RAST) ([@B4]) and the Bacterial Annotation System (BASys) ([@B5]). Multilocus sequence typing (MLST) was performed using a local BLAST search to identify the seven gene loci (i.e., *arcC*, *aroE*, *glpF*, *gmk*, *pta*, *tpi*, and *yqiL*) as described in Enright et al. ([@B6]). The *spa* type was assigned using DNAGear ([@B7]).

Altogether, 70 contigs were obtained from the *de novo* assembly, with an accumulated length of 2,763,469 bp and a G+C content of 32.6%. A total of 2,569 coding sequences (CDSs) were identified and annotated. Of the CDSs, 4.2% were associated with the cell wall and capsule, 3.5% are associated with virulence, disease, and defense mechanisms, and 2.9% are related to the stress response, which contributes to adaptation in the host and survivability. Meanwhile, 3.19% are related to membrane transport, part of which is believed to contribute to the antibiotic resistance mechanism of the strain. Genotypically, *S. aureus* KT/Y21 is of the sequence type 772 (ST772) lineage, *spa* type t657, and *agr*II and *dru* type dt10ao. KT/Y21 also harbors the PVL pathogenic genes. Clinical isolates of *S. aureus* of the same ST772 lineage and that are PVL positive have been reported in Malaysia ([@B8]). These isolates might have originated from Bangladesh due to similarities with the so-called Bengal Bay Clone ST772 lineage ([@B9], [@B10]), as there are many Bangladeshis working as laborers and contract workers in Malaysia.

The *S. aureus* KT/Y21 genome also contains genomic islands, such as the staphylococcal cassette chromosome *mec* element (SCC*mec*) with a type V *ccrC* complex, the νSaα and νSaβ pathogenicity islands, and the PVL prophage ([@B11]). However, no plasmids were identified from the draft genome sequence. Sequencing *S. aureus* KT/Y21 has generated the first draft genome of an ST772 lineage from Malaysia, thus providing a reference for future comparative genomics of this important pathogen.
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This whole-genome draft sequence project has been deposited at DDBJ/EMBL/GenBank under the accession no. [AOCQ00000000](http://www.ncbi.nlm.nih.gov/nuccore?term=AOCQ00000000). The version of the genome described in this paper is the first version (GenBank accession no. AOCQ01000000).
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